Phibro Animal Health (PAHC) - יתרת חוב לטווח ארוך להון עצמי

Supplies of veterinary products and feed additives generate a steady cash flow, with the current figure standing at 1.91. The linear price action on the chart links financial performance to the activities of Phibro Animal Health (PAHC) in developing vaccines for swine and poultry farming. The business relies on large-scale agricultural producers, covering the global livestock health market. The global distribution of preparations ensures farm biosecurity and the continuity of food supply chains.

Phibro Animal Health ensures fundamental environmental safety in the production of veterinary drugs, focusing on the control of industrial emissions and chemical disposal. An analysis of the long-term debt-to-net assets ratio allows for an assessment of the share of multi-year liabilities in equity, which determines the business's financial resilience to market shocks and minimizes bankruptcy risk amid changing market conditions.